Mocaer E - Search Results

1

Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice.

Egeland M, Zhang X, Millan MJ, Mocaer E, Svenningsson P. Egeland M, et al. Among authors: mocaer e. J Neurochem. 2012 Dec;123(5):811-23. doi: 10.1111/jnc.12011. Epub 2012 Oct 10. J Neurochem. 2012. PMID: 22957735 Free article.

2

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.

Millan MJ, Svenningsson P, Ashby CR Jr, Hill M, Egeland M, Dekeyne A, Brocco M, Di Cara B, Lejeune F, Thomasson N, Munoz C, Mocaër E, Crossman A, Cistarelli L, Girardon S, Iob L, Veiga S, Gobert A. Millan MJ, et al. Among authors: mocaer e. J Pharmacol Exp Ther. 2008 Feb;324(2):600-11. doi: 10.1124/jpet.107.132563. Epub 2007 Nov 16. J Pharmacol Exp Ther. 2008. PMID: 18024787

3

Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.

Soumier A, Banasr M, Lortet S, Masmejean F, Bernard N, Kerkerian-Le-Goff L, Gabriel C, Millan MJ, Mocaer E, Daszuta A. Soumier A, et al. Among authors: mocaer e. Neuropsychopharmacology. 2009 Oct;34(11):2390-403. doi: 10.1038/npp.2009.72. Epub 2009 Jul 1. Neuropsychopharmacology. 2009. PMID: 19571795

4

The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.

Peng XQ, Ashby CR Jr, Spiller K, Li X, Li J, Thomasson N, Millan MJ, Mocaër E, Muńoz C, Gardner EL, Xi ZX. Peng XQ, et al. Among authors: mocaer e. Neuropharmacology. 2009 Mar;56(4):752-60. doi: 10.1016/j.neuropharm.2008.12.007. Neuropharmacology. 2009. PMID: 19136017 Free PMC article.

5

The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures.

Millan MJ, Buccafusco JJ, Loiseau F, Watson DJ, Decamp E, Fone KC, Thomasson-Perret N, Hill M, Mocaer E, Schneider JS. Millan MJ, et al. Among authors: mocaer e. Int J Neuropsychopharmacol. 2010 Sep;13(8):1035-51. doi: 10.1017/S1461145710000775. Epub 2010 Jul 22. Int J Neuropsychopharmacol. 2010. PMID: 20663270 Free article.

6

The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.

Millan MJ, Gobert A, Roux S, Porsolt R, Meneses A, Carli M, Di Cara B, Jaffard R, Rivet JM, Lestage P, Mocaer E, Peglion JL, Dekeyne A. Millan MJ, et al. Among authors: mocaer e. J Pharmacol Exp Ther. 2004 Oct;311(1):190-203. doi: 10.1124/jpet.104.069625. Epub 2004 May 14. J Pharmacol Exp Ther. 2004. PMID: 15146031

7

Agomelatine, the first melatonergic antidepressant: discovery, characterization and development.

de Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ. de Bodinat C, et al. Among authors: mocaer e. Nat Rev Drug Discov. 2010 Aug;9(8):628-42. doi: 10.1038/nrd3140. Epub 2010 Jun 25. Nat Rev Drug Discov. 2010. PMID: 20577266 Review.

8

Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.

Norman TR, Cranston I, Irons JA, Gabriel C, Dekeyne A, Millan MJ, Mocaër E. Norman TR, et al. Among authors: mocaer e. Eur J Pharmacol. 2012 Jan 5;674(1):27-32. doi: 10.1016/j.ejphar.2011.10.010. Epub 2011 Oct 21. Eur J Pharmacol. 2012. PMID: 22040921

9

Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress.

Dagytė G, Crescente I, Postema F, Seguin L, Gabriel C, Mocaër E, Boer JA, Koolhaas JM. Dagytė G, et al. Among authors: mocaer e. Behav Brain Res. 2011 Mar 17;218(1):121-8. doi: 10.1016/j.bbr.2010.11.045. Epub 2010 Nov 27. Behav Brain Res. 2011. PMID: 21115070 Free article.

10

Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety.

Rainer Q, Xia L, Guilloux JP, Gabriel C, Mocaër E, Hen R, Enhamre E, Gardier AM, David DJ. Rainer Q, et al. Among authors: mocaer e. Int J Neuropsychopharmacol. 2012 Apr;15(3):321-35. doi: 10.1017/S1461145711000356. Epub 2011 Apr 8. Int J Neuropsychopharmacol. 2012. PMID: 21473810 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters